Phytohormones influence many diverse developmental processes ranging from seed germination to root, shoot, and flower formation. Recently, mutational analysis using the model plant Arabidopsis thaliana has been instrumental in determining the individual components of specific hormone signal transduction pathways. Moreover, epistasis and suppressor studies are beginning to explain how these genes and their products relate to one another. While no hormone transduction pathway is completely understood, the genes identified to date suggest that simple molecular rules can be established to explain how plant hormone signals are transduced. This review describes some of the shared characteristics of plant hormone signal transduction pathways and the properties for informational transfer common to many of the genes that specify the transduction of the signal.
INTRODUCTION
Approximately 100 years ago, the German botanist Julian von Sachs suggested that plant growth and development may be controlled by specific endogenous plant substances. We now know that a small group of compounds, termed growth regulators or phytohormones, mediate many diverse plant processes. However, even with the protagonists in hand, the roles of these substances in plant development are still unclear. For example, within a plant, a single hormone can regulate many different processes and at the same time different hormones can influence a single process. Does the flexibility of hormone action contribute to the plasticity of plant development or is it a consequence? The complexities of hormonal responses have given rise to protracted speculation as to the logic of hormones' action, but this debate has contributed little to our understanding of plant hormone biology. Understanding the intricacies of plant hormones requires first the identification of the molecules that participate in transducing the hormone signal into a cellular response. With this information in hand, rather than questioning the logic, logical questions can be asked. For example, do different hormone pathways use similar signaling molecules and do different cells, tissues, or even species of plants use all or only some of the same steps? The application of genetic analysis to hormone signaling has begun to provide some answers. Genetics is a powerful tool for establishing in vivo links between the signal and the response because inferences can be made based solely on plant mutant phenotypes. Furthermore, when combined with molecular analysis, these functional relationships can be witnessed biochemically.
Genetic analysis requires an experimental system in which a large number of mutations affecting the response of the plant to a particular hormone can be easily identified. Coupled with the ability to cross, complement, and map mutations, these saturation mutagenesis experiments can determine the number, the types, and the nature of gene products involved in the signaling pathway. Although a number of genetically tractable plant species exist, the small crucifer Arabidopsis thaliana (Arabidopsis) has dominated hormone signal transduction studies. This review focuses on this body of work. The popularity of Arabidopsis for mutant screens involving hormones stems not only from its favorable genetics but also from the plant's ability to grow on petri plates under sterile conditions. This growth attribute allows large-scale screening of individuals under completely defined growth conditions, thereby allowing plant mutational screens to be achieved with a microbiologist's technique (10 3 seeds on a single petri plate). Mutants with increased or reduced sensitivity to a particular growth regulator are often easily identified in the uniform background of normally responding wild-type plants.
Excellent reviews on the genetic dissection of hormone signaling in Arabidopsis have recently been published (13, 16, 22, 25, 36, 52, 71) and, therefore, the use of genetics is not discussed in detail here. We have now reached a stage where the characteristics of a typical signaling pathway give some predictive value as to the types of genes that encode signaling components. This review aims to show that it is now possible to formulate simple rules to explain how genetic analysis can dissect a signal transduction pathway. First, I define the properties necessary for a hormone signal to be transduced and describe how allelic forms of genes encoding components involved in the pathway reflect these properties. Second, since an informational pathway by definition involves interactions, I present a range of examples of how genetic analysis has been used to understand these underlying interactions. Finally, I refer briefly to new methods to further our understanding of the genetic basis of hormone signaling transduction.
GENETIC IDENTIFICATION OF HORMONE SIGNALING GENES

Signal Transduction Pathways
Signal transduction designates a specific information pathway within a cell that translates an extrinsic signal into a specific cellular response. The initial phase before the signal is transduced requires high-affinity binding of the hormone to a specific receptor protein. Although the chemical nature of plant hormones does not predict the cellular location of the receptor, the binding event must cause the receptor to undergo a conformational change to initiate the transduction of the signal. Once activated, the receptor could alter gene expression directly by acting as a transcription factor, as is the case with the mammalian glucocorticoid receptor (6) . Formally, in this scenario, there is no signal transduction pathway. Alternatively, the receptor may pass the signal to the nucleus through a series of intermediary steps that define the length of the transduction pathway. If a signal transduction pathway exists downstream of the receptor, the stimulation of the receptor must activate or inactivate relay components of the pathway through some type of cascading mechanism. Often the signaling components are modified by a phosphorylation event or by the binding and hydrolysis of a guanine nucleotide (54, 69) . In these cases, the protein acts as a molecular switch, depending on its conformational state. These epigenetic changes in signaling proteins permit rapid response to the hormone signal and, more important, because they are epigenetic these changes are readily reversible. This therefore allows the signal to be shut down rapidly. This reversibility also allows the recycling of the components of the signaling system so that they can receive further signals.
The epigenetic nature of the signaling components of a transduction pathway allows predictions to be made as to the types of mutations that will disrupt normal signaling. In principle, it is possible to identify allelic states of a signaling component that mimic one of the two epigenetic conformations. Dominant alleles define high-level or constitutive activity, whereas null lossof-function alleles would have reduced or no activity. For example, if a protein must be phosphorylated to activate the next step in the signaling pathway, lossof-function mutations in this gene will cause loss of the signal. Conversely, mutations that lock the protein into an activated conformation will constitutively activate the pathway. If loss-and gain-of-function alleles have opposite effects on hormone sensitivity, during normal signaling the differential states of these gene products should specify the signal to turn on or turn off. Moreover, if components act as binary switches, it should be possible to determine how a switch is set and how that state regulates the signal. Thus, as mutations are identified for each protein in the pathway, they can be classified into either positive or negative regulators of that pathway.
Identification of Response Mutants Using Hormone Application
The simplest method to identify mutations in genes involved in hormone signaling is by assaying a mutagenized population for an altered response to supplied hormone. To be useful, a clear and reproducible response must occur in wildtype plants in the presence of the hormone. For example, ethylene gas mediates many plant processes ranging from seed germination to senescence of flowers, fruits, and leaves (36) . Most of these responses, however, are variable in their penetrance and therefore are difficult to assay in genetic screens. By contrast, exposure of dark-grown seedlings to exogenous ethylene reproducibly inhibits root and hypocotyl elongation, and causes radial swelling of the hypocotyl and exaggerated apical hook growth (51) . Collectively known as the ethylene triple response, this simple growth assay for ethylene action made it possible for a number of laboratories to design visual screens to obtain the desired mutants (5, 24) . Screening mutagenized populations of dark-germinated Arabidopsis seedlings for plants displaying an absence of a triple response in the presence of ethylene yields mutants insensitive to the hormone. Conversely, dark-grown seedlings that show a triple response in the absence of ethylene identify constitutive response mutants. Analogous screens for mutations that alter the germination response to exogenous abscisic acid (ABA) (20, 40) or gibberellin (GA) biosynthetic inhibitors (33) and growth responses to auxin (19, 47) , brassinosteroid (BR) (15) , cytokinin (18) , and jasmonate (3) have allowed the identification of a large number of mutants in Arabidopsis for these hormonal responses. The use of hormone application as a selective agent, however, must be judicious since the screening procedure is artificial. In most of these screens, seeds and seedlings are exposed to higher concentrations of hormone than experienced under normal growth conditions. Mutations that confer insensitivity to such conditions may not always be specific to the hormonedependent pathway of interest.
Identification of Response Mutants Using Auxotrophic Phenotypes
A second method to screen for mutations that affect hormone signaling involves identifying plants that display phenotypes similar to mutants that are deficient in the synthesis of a particular hormone. However, unlike auxotrophic mutants, these mutants are nonresponsive and, therefore, are not rescued by application of the hormone. For example, a number of mutants deficient in BR biosynthesis in Arabidopsis have a characteristic cabbage-like appearance and grow as dark green dwarves if not sprayed with BR (2, 46, 72) . Based on this auxotrophic phenotype, Li & Chory (45) identified one complementation group, designated bri1, by screening mutagenized populations of Arabidopsis for nonresponsive BR dwarves. The bri1 mutations are allelic to a previously characterized BR-insensitive mutant that had been identified by its ability to show normal root growth on exogenous BR (15) . The BRI1 gene appears to encode a putative receptor kinase (45) . Although binding of BR to this protein has not been shown, this particular screening method did indeed identify a candidate gene for a hormone transduction pathway. Similar approaches based on the dwarfed phenotype of GA auxotrophs have allowed the identification of potential GA-response mutants in a variety of plant species (71) . The phenotypic similarities of nonresponsive mutants and biosynthetic auxotrophs can, however, be deceiving. Phenotypic analysis of the auxotroph must be precise. For example, a number of BR auxotrophic mutants in barley were originally classified as GA-response mutants because the plants did not respond to applied GA (59) . Second, although mutations affecting biosynthesis may have dramatic effects on the development of many tissues in the plant, signaling components of a response pathway may be redundant. Thus, mutations in any one component gene may only give subtle phenotypes or perhaps influence only a subset of development, which in turn leads to unexpected phenotypes. This latter case may explain why the BR nonresponsive screen only identified bri1.
Altered response to applied hormone or nonresponsive mutants that phenocopy hormone auxotrophs are not a sufficient genetic criterion to identify a gene involved directly in signal transduction (i.e. a gene product whose primary function is involved in transducing the hormone signal). It is possible that mutations identified in such screens mark genes whose functions are necessary for a signaling event to occur but are not directly involved in the signal transduction pathway. Although a hormone may transduce its signal through a conserved pathway in different tissues, the developmental states of the tissues may attenuate or amplify the signal's current. For example, the amount of GA needed to rescue the germination defect of an Arabidopsis auxotroph is orders of magnitude lower than that needed to restore normal growth stature (41) . Thus, genetically perturbing the developmental commitment of a tissue may change the ability of that tissue to respond to the hormone. However, as noted above, proteins involved in signaling pathways usually act as binary switches and therefore it should be possible to identify mutations that result in opposite phenotypes. Because a gain-of-function mutation does not eliminate gene function, this allelic form can exclude genes whose function is required for a developmental event to occur but is not necessary for the signal transduction pathway.
Hormone Response Mutants
Using the approaches mentioned above, a number of laboratories have obtained a variety of mutants affecting hormone responses in Arabidopsis. These mutations and the cloning of their wild-type alleles have been instrumental in identifying individual components involved in a signaling pathway. Below I describe a small number of these, concentrating on how such mutants allow the presence of switch genes in a hormone signaling pathway to be established. ETHYLENE TRIPLE RESPONSE MUTANT, etr1 Dominant mutations in the ETR1 gene of Arabidopsis were identified by the inability of dark-grown seedlings to perform the triple response in the presence of ethylene (5) . Other phenotypes associated with the etr1 mutation include poor seed germination, decreased senescence of detached leaves, and reduced ethylene-induced gene expression in vegetative tissue. The ETR1 gene encoded a protein with sequence similarity to bacterial two-component histidine kinases (11) . Unlike their bacterial counterparts, however, the Arabidopsis kinase and response regulator domains are both localized to the carboxyl terminal of the ETR1 protein. All etr1 mutations clustered to the amino termini of the protein, which contains a novel motif necessary for ethylene binding (21, 30, 65) . These results strongly suggest that the ETR1 protein encodes an ethylene receptor. Four ETR1-like histidine kinases have been cloned in Arabidopsis, and mutations in a number of these genes confer ethylene insensitivity to the plant (27) (28) (29) 64) . The dominant insensitivity phenotype of etr1 in the presence of multiple wild-type ethylene receptor proteins may mean that the wild-type ETR1-like proteins function as negative regulators of ethylene responses in the absence of ethylene. Ethylene inhibits wild-type ETR1 function, whereas etr1 mutants do not recognize ethylene and therefore show a dominant insensitivity. Alternatively, mutant ETR1 protein may function to poison the ETR1 family of wild-type complexes. The strong dominance of the etr1 mutations over the complete ETR1 gene family, however, makes this latter possibility seem less likely (36) .
CONSTITUTIVE TRIPLE RESPONSE MUTANT, ctr1 Recessive ctr1 mutants of Arabidopsis display the ethylene triple response in dark-grown seedlings and constitutive expression of ethylene-regulated genes in the absence of ethylene (37) . Mutant plants have compact dwarfed rosettes and smaller roots, both phenotypes that can be phenocopied by exposing wild-type plants to ethylene. The observation that ctr1 mutants do not overproduce ethylene suggests that the CTR1 gene product acts as a negative regulator of ethylene signaling and as a consequence, loss-of-function mutations in this gene confer an ethylene constitutive phenotype. The amino acid sequence of the CTR1 gene most closely resembles the Raf family of mammalian protein kinases (37) , which suggests a phosphorelay is involved in transduction of the ethylene signal. Although sequenced mutations in the CTR1 gene demonstrate that ctr1 phenotypes are due to a loss-of-function, the lack of gain-of-function mutations in CTR1 has not allowed the assignment of CTR1 as switch gene. Furthermore, that the amino-terminal end of the CTR1 diverges from other Raf kinases suggests this protein may be regulated by novel mechanisms in plants. The recent report that CTR1 and ETR1 proteins can interact in a two-hybrid yeast assay (14) implies that, unlike other biological systems, in plants the bacterial-like ETR1 receptor may interact directly to the CTR1 mammalian-type kinase.
ETHYLENE-INSENSITIVE MUTANT, ein3
Recessive mutations in the ein3 gene of Arabidopsis have similar phenotypes to etr1 mutants in that plants show reduced response to ethylene (62) . The EIN3 gene encodes a novel nuclear-localized protein that shares similar protein domains to known eukaryotic transcriptional activators (12) . All ein3 alleles so far sequenced appear to be loss-of-function mutations, which suggests that this gene is a positive activator of ethylene response (12) . Furthermore, transgenic plants overexpressing EIN3 show constitutive ethylene responses similar to those observed in ctr1 loss-of-function alleles (12) . Thus, EIN3 fulfills the binary switch properties of a signaling molecule in that it is both necessary and sufficient for the ethylene response pathway in Arabidopsis. Ecker and co-workers have suggested a number of models to explain these results (12) . The EIN3 protein may be positively activated by the ethylene signal and overexpression of the gene may result in increased EIN3 activity. Another possibility is that EIN3 is under negative regulation and exposure to ethylene alleviates this inhibition. If true, high EIN3 levels may titrate the negative regulators and lead to ethylene-independent activation of ethylene responses. These models predict that the EIN3 protein recognizes either a positive or negative signal. Whichever is the case, the outcome of specific mutations in the EIN3 gene could differentiate between these possibilities. Mutations that abolish the positive interaction should produce an EIN3 loss-offunction phenotype. Alternatively, if EIN3 is negatively regulated, disruption of this interaction may yield a constitutive ethylene response.
ABA-INSENSITIVE MUTANT, abi1 AND abi2 ABA-insensitive mutants of Arabidopsis were identified by their ability to germinate on concentrations of ABA that normally inhibit wild-type (20, 40) . One ABA-insensitive locus, designated ABI1, encodes a protein type 2C phosphatase, which indicates that protein phosphorylation and dephosphorylation are involved in ABA signaling (43, 48) . Only one specific dominant mutation in ABI1 (abi1-1) confers reduced ABA responses to the plant at both embryonic and vegetative levels. Biochemical characterization of abi1-1 protein suggests that this mutation acts in a dominant-negative fashion (4). Interestingly, an identical mutation in a second gene (abi2-1) that also encodes a type 2C phosphatase also confers an ABA-insensitive phenotype to the plant (44, 61) . The functional and molecular redundancy of these genes may explain why mutations in either gene must be dominant to confer ABA insensitivity. In this scenario, abi1-1 mutant protein would not only have reduced activity but would also interfere with an ABA signaling complex that might include the ABI2 wild-type protein. Unfortunately, loss-of-function mutations of both genes do not exist to verify this hypothesis. Such double mutants should also be insensitive to exogenous ABA. If ABI1 and ABI2 are molecular switch genes in the ABA signaling pathway, thenoverexpression of the ABI1 or ABI2 wild-type gene products should confer a supersensitive phenotype to the plant. Although this experiment has not been done, the identification of single mutations that enhance the sensitivity of the plant to exogenous ABA (17) implies that signal current in the ABA pathway can be increased by simple genetic variation.
ABA-INSENSITIVE MUTANT, abi3
Severe alleles of abi3 are of interest because this mutant's phenotypes are restricted to late seed maturation, which suggests that this gene may mark a developmental branch in the ABA signaling pathway (50, 53) . The ABI3 gene appears to encode a seed-specific transcriptional activator whose expression patterns reflect the abi3 mutant phenotypes (23) . Misexpression of ABI3 protein causes seed-specific mRNA transcript accumulation in vegetative tissues, which indicates that this gene is sufficient to regulate gene expression in seed. Although this result supports a binary switch role for ABI3, other criteria defining this gene as a component of ABA signaling are not met. First, many defects observed in the loss-of-function null alleles are not in processes that are perturbed in ABA auxotrophs (55) . Second, seeds from transgenic plants overexpressing ABI3 do not show the expected enhancement of ABA responses such as increased sensitivity to exogenous ABA or hyperdormancy (7). These results have led to the suggestion that ABI3 could encode a developmental regulator that is necessary for correct implementation of seed ABA signaling rather than encoding an integral component of the signaling pathway (Figure 1 ). In this instructive role, ectopic expression of ABI3 could alter the developmental state of cells, for example, by changing the stoichiometry of ABA signaling components. Consistent with this hypothesis, loss of ABI3 function would result in a cell state that would be unable to respond to ABA. Consequently, ABI3 may be a molecular switch gene in seed development but not necessarily a signaling component in ABA transduction.
GENETIC INTERACTION BETWEEN SIGNALING COMPONENTS
Mutational screens that perturb plant hormonal responses permit insights into the underlying mechanisms of how individual gene products contribute to transducing a hormone signal. However, how these genes interact to transduce the signal is often not obvious. In relaying the signal, the protein can either positively or negatively regulate the next component of the signaling pathway. Sometimes these interactions can be determined biochemically, but often these studies inform us only of the molecular mechanism of interaction and not the sign of the relay. The interplay between component states in a signaling pathway can be further determined by examining the phenotypes of plants containing two mutations that affect a signaling pathway. In some cases, this analysis is carried out by constructing double mutant strains between well-defined signal transduction mutants. Alternatively, if few mutations exist for a particular pathway, a mutant can be used as starting material to find new genetic interactions.
Epistasis
If one mutation can completely mask the phenotype of another and replace it with its own, it is termed epistatic. To be interpretable, epistatic analysis has rigorous genetic rules (1) . First, the recessive mutations must be nulls because intermediate signaling states due to leaky alleles can give ambiguous results. Thus, the molecular basis of the mutations must be known. Second, the two mutations used must have clearly distinct phenotypes such as insensitivity in the presence of the hormone and constitutive response in the absence of the hormone. In cases where the two mutations confer opposite signaling states, the epistatic mutation will be genetically downstream (Figure 2) . If the mutations have the same signaling state, for example, when one molecule activates another component that also activates the signaling response, then the epistatic mutation is genetically upstream. This example is analogous to epistasis in a simple linear metabolic pathway in which the earlier intermediate accumulates in the double mutant. However, mutations that confer similar signaling states in a hormone transduction pathway often have indistinguishable phenotypes and, therefore, cannot be interpreted. For example, epistatic analysis between two loss-offunction mutations that both lead to hormone insensitivity may not distinguish whether the genes act in one linear pathway or two converging branches of a parallel pathway. Figure 2 Epistasis between mutations that confer opposite signal states in a hormone transduction pathway. In wild-type when the hormone is present, the signal is ON; when it is absent, the signal is OFF. Loss-of-function insensitive mutants divert the signal state to OFF even in the presence of the hormone. Gain-of-function constitutive mutants divert the signal to ON even in the absence of hormone. In this double mutant example, the gain-of-function mutation affects a gene product that works downstream of the loss-of-function mutation. In the double mutant the signal is eventually diverted to ON and thus the gain-of-function mutation is epistatic to the loss-of-function mutation.
Even if constitutive gain-of-function and recessive loss-of-function mutations exist for each step of the pathway, epistatic analysis can be deceptive. Many mutations may interact through independent regulatory mechanisms rather than within a dependent pathway. For example, the failure of Arabidopsis embryo lethal mutants to germinate, which is a similar phenotype to a GA auxotroph, is not due to any direct involvement in GA signaling. Both mutations impinge on germination but not on the same dependent pathway. Moreover, even in a dependent pathway, the products of one signaling gene may modify the activity of a number of downstream components or may be modified by multiple regulators, which leads to branches or convergence. These nodal pathways add a further level of complexity to interpretations of double-mutant phenotypes. These examples demonstrate why epistatic analysis alone is not sufficient to determine molecular mechanisms of gene action. In general, a combination of molecular and classical genetics is required to confirm a genetic model.
The hormone signaling pathway that has been studied the most extensively at the genetic and molecular level is the ethylene transduction pathway, and the phenotypes of the mutants have been discussed above.
Ethylene Pathway Interactions
Interactions between various ethylene-response mutants have been studied by examining double mutant phenotypes between mutations that show opposite signaling states in the presence and absence of the hormone. For example, ctr1 mutants that give a constitutive ethylene response are epistatic to ethyleneinsensitive etr1 mutants, which suggests that CTR1 is genetically downstream of ETR1 (37) . Two possible models emerge based on this interaction. In one case, in the absence of ethylene, the ETR1 receptor constitutively activates CTR1, which inhibits ethylene responses downstream. The addition of ethylene inhibits the ETR1 activation of CTR1, thereby releasing ethylene-response genes from CTR1 inhibition ( Figure 3A) . In the second model, ETR1 is activated by ethylene to inactivate CTR1 function ( Figure 3B ). Again in this model CTR1 negatively regulates ethylene action downstream. An essential difference between these two models is that the former predicts that ethylene inhibits a positive regulator whereas in the latter, the gas activates a negative regulator. The identification of alternative allelic states of ETR1 can discriminate between these possibilities; however, the redundancy of the ETR1-like receptor kinases makes the phenotypic identification of loss-of-function ETR1 alleles difficult. Despite this problem, loss-of-function alleles for each ETR1 homologous gene were identified by screening directly for loss of ethylene insensitivity in each of the ETR1-like mutants (28) . Selection against dominant insensitivity is advantageous since the phenotype is unambiguous and there is no preconceived bias on the phenotype of ETR1 loss-of-function alleles. As expected, each loss-offunction mutation by itself had no observable phenotype; nevertheless, when combined, quadruple mutant plants are phenotypically similar to a ctr1 mutant. If ETR1 only regulates CTR1 in the presence of ethylene and has no function in the absence of the gas, as suggested in the second model ( Figure 3B ), genetic loss of the ethylene reception should have no effect on the plant's development in the absence of ethylene. Because the quadruple mutant mimics ctr1 in the absence of ethylene, the ethylene receptor must activate CTR1 in the absence of the gas. It follows then that ethylene inhibits the ETR1 activation of CTR1 ( Figure 3A) .
Epistatic analysis of CTR1 with other ethylene-insensitive genes EIN2, EIN3, EIN5, EIN6, and EIN7 suggests that these genes act downstream of CTR1 (62) . The recent cloning and demonstration that EIN3 overexpression confers an ethylene constitutive response in Arabidopsis have allowed the genetic placement of this gene in the ethylene signal transduction pathway. The constitutive ethylene response observed in ectopically expressed EIN3 seedlings is independent of ein2 loss-of-function alleles, which suggests that EIN3 acts genetically downstream of EIN2 (12) . Since other ein mutants are recessive loss-of-function ethylene-insensitive mutations, the use of gain-of-function EIN3 overexpression plants should allow placement of the other EIN genes in the pathway.
These studies of the genetics of ethylene signal transduction indicate that epistatic analysis can be used to infer gene order in a dependent pathway in plant hormone signaling. Similar analysis should be possible for other hormone pathways as more mutations are identified. However, even for ethylene signaling, more allelic states are required for each of the genes involved. As genes are cloned, overexpression studies can function as dominant gain-offunction alleles, but caution must be used. Overexpression of regulatory genes is problematic since the gene product accumulates to artificial levels and is produced ubiquitously. In this sense, gain-of-function mutations that maintain wild-type levels and normal localization of protein may be less prone to artifact. For example, ectopic expression of a related gene to EIN3, designated EIL1, results in ethylene-independent activation of ethylene responses, and these responses are independent of EIN2 function (12) . The EIL1 gene product, however, may act in a disparate pathway that when misexpressed interferes with ethylene signaling. Until loss-of-functional alleles of EIL1 are identified, a neomorphic function for EIL1 overexpression in ethylene signaling cannot be discounted.
Interactions Between Signaling Pathways
Physiological studies have demonstrated that plant growth and development require the coordinated action of multiple hormones and that these interactions are often reflected in the phenotypes of hormone-response mutants. The axr2 mutation in Arabidopsis, for example, confers insensitivity to auxin, ethylene, and ABA (78) . Altered sensitivities to more than one hormone can cause a dilemma as to which signaling pathway is perturbed and can confound genetic screens. In Arabidopsis, for example, the ckr1 mutation confers a reduced response to exogenous cytokinin at the level of root elongation and was therefore catalogued as cytokinin insensitive (70) . Subsequent genetic analysis has shown this mutation is allelic to the ethylene-insensitive ein2 mutation (10). Cytokinin induces ethylene biosynthesis because this hormone positively regulates an isoform of 1-aminocyclopropane-1-carboxylate synthase, the first step in ethylene biosynthesis (74) . Cytokinin insensitivity is due to the inability of ckr1 to respond to the ethylene production induced by cytokinin, not to the cytokinin directly.
Although mutants with altered sensitivity to one hormone need not be defective in that particular signaling pathway, such mutants do establish relationships between signaling pathways and can lead to new genetic screens. The inability to induce ethylene in the presence of cytokinins results in a loss of the triple response in dark-grown Arabidopsis seedlings, and this assay has been the basis of a genetic screen for mutants with altered cytokinin responses (73) . To date, four classes of mutants, designated cin for cytokinin insensitive, are unable to show a triple response in the presence of cytokinin. Although these mutants should offer insights into cytokinin signaling events, the ethylene-cytokinin interactions reinforce the importance of good phenotypic characterization of hormone response mutants.
Another, and potentially more interesting, mechanism of interacting hormone responses is the possibility that the same gene products are used in different signaling pathways. If signaling components are promiscuous, different hormones could fulfill similar functions due to cross talk. For example, auxin, GA, and cytokinin can all induce cell division in different tissues, which suggests the downstream signal output from activation by these hormones is funneled into control of the cell cycle. Based on what is currently known about mutations that confer changes in sensitivity to multiple hormones, it is difficult to test this possibility. However, genetic analysis of auxin response in Arabidopsis suggests that proteins involved in correct auxin response interact with cell cycle components to regulate the response of plant cells to this hormone (57) .
Suppressor Mutations
Although epistasis is useful in determining the order of gene products in a dependent pathway, the architecture of a signaling pathway often does not allow for simple epistatic interactions. Divergence and convergence of pathways, for example, may not lead to clear double mutant phenotypes. A potential genetic method of determining relationships in complex interactions is by suppression analysis. Not to be confused with epistasis, a suppressor mutation either partially or completely restores the phenotype to wild-type but does not substitute its own. Although the criterion for genetic suppression is less restrained than that of epistasis, analysis of suppressor mutations can be laborious. If suppressor mutations have no obvious phenotypes on their own, segregation, complementation, and mapping experiments are limited to systems with good genetic maps. Second, although the suppressor net is cast widely, genes identified in these screens may have little to do with the transduction of the pathway of interest. For example, one suppressor mutation affecting cytokinin-dependent ethylene production is a new allele of fus9/cop10 (73) . Although this is a nice demonstration of the interaction between this hormone and light signaling, there is probably no direct role for fus9/cop10 in cytokinin signaling per se.
Broadly speaking, in hormone signaling pathways the two most useful compensating changes that result in suppression are intragenic and extragenic mutations. Intragenic suppressors are often identified by selecting for loss of a dominant gain-of-function phenotype such as suppressing hormone insensitivity. As demonstrated in etr1 suppressor screens (28) , this strategy can be extremely useful when trying to generate alternative allelic states for a gene of interest.
Extragenic suppressors or second-site revertants restore normal function to a pathway by changing another function in the pathway. These mutations often uncover genes in a transduction pathway by causing a shift in the signal flux. Depending on the nature of the signaling genes being suppressed (i.e. positive or negative), mutations in genes elsewhere in the pathway may either decrease or increase the signal current. Moreover, if the pathway is exquisitely sensitive to perturbation in signaling flux, it may be possible to identify suppressor mutations in a heterozygous state. These mutations will be dominant suppressors of the original mutation and may display new phenotypes when homozygous in a wild-type genetic background. Suppressors demonstrating new phenotypes on their own are not only useful for identifying new gene functions but also for identifying new mutations in previously characterized genes. Genes encoding components of a particular signaling pathway may have other functions that may be missed by direct screening but can be identified genetically among suppressor mutations of signaling mutants.
Hormones affect many aspects of plant growth and development, with the result that mutations affecting early steps in the response pathway usually result in pleiotropic phenotypes. By contrast, if output branches exist further down the transduction pathway, mutations in these steps will only affect subsets of hormone-regulated functions. Comparably, extragenic suppressors that bypass all the phenotypes of an original mutation most probably identify genes that interact closely with the allele being suppressed. In the extreme case, allelespecific suppressor mutations indicate that the two gene products most likely interact biochemically. Conversely, extragenic mutations that only suppress a subset of original phenotypes probably are further away from the function being suppressed. For example, loss-of-function hookless1 mutations in Arabidopsis only affect apical hook growth in response to ethylene, and both genetic and molecular studies confirm that this gene is downstream of early ethylene signaling events (42) .
Suppressor Analysis of the GA Signaling Pathway
GA-deficient mutants have been extremely useful to understanding the roles of GA in plant growth and development (26) . Mutants deficient in GA synthesis display a number of phenotypes, including poor germination, dwarfed growth habit due to reduced cell expansion, underdeveloped petal and stamen development, delayed flowering, and delayed senescence (26, 71) . Using the phenotypes of GA auxotrophic mutants as a guide, GA-response mutants have been identified in a number of plant species including Arabidopsis (52, 71) . Generally, these mutants fall into two categories, dominant or semidominant mutations that result in a reduced sensitivity to GA, and recessive mutations that confer a GA-independent phenotypes to the plants. Below I describe the phenotypes of a number of GA response mutants, focusing on how suppressor analysis has been used to further our understanding of how these genes function in GA signal transduction.
GIBBERELLIN-INSENSITIVE MUTANT, gai1
A semidominant gai1-1 mutation causes Arabidopsis plants to grow as dark green semidwarf, with reduced fertility and germination (38) . Although these phenotypes are similar to GAdeficient mutants, the lack of rescue of gai1-1 by GA application suggests this mutation results in reduced GA responsiveness. Intrallelic suppressor mutations of gai1-1 were identified by screening for rescue of the gai1-1 semidwarf phenotype. Early phenotypic characterization suggested these intrallelic mutations did not confer any profound developmental phenotypes to the plant (56, 79) . Subsequent physiological studies, however, have demonstrated that these suppressor plants are weakly GA independent in that they are slightly insensitive to GA biosynthetic inhibitors (56) . The GAI1 protein has sequence identity to a number of known transcriptional activators, and the semidominant gai1-1 allele contains an inframe 51 base-pair insertion mutation (56) . More important, the gai1-1 intrallelic suppressor mutations all disrupted the GAI1 open reading frame, which indicates that these are loss-of-function alleles. Although the GA-independent phenotype of these alleles is weak, this loss-of-function phenotype suggests that this protein may have binary switch properties of a signal transduction component. With this in mind, Harbord and co-workers (56) have posited a model to explain GAI1 action in plant GA responses. Wild-type GAI1 may negatively regulate cell elongation and this function is inhibited by GA. In this model, the semidominant gai1-1 mutant has lost the capacity to be antagonized by GA, thereby allowing the protein to continuously inhibit cell elongation. If GA interacts directly with GAI1, there may be no GA signal transduction pathway per se since GAI1 appears to encode a transcription factor. Alternatively, if GAI1 interacts with a GA signaling component, this interaction is at the end of the GA signaling pathway. Whichever is the case, the finding that gai1-1 GA auxotrophic double mutants produce a more severe dwarf phenotype indicates that GA can still be perceived in the gai1-1 mutant. Hence, GAI1 is not the sole component of GA signaling in Arabidopsis.
REPRESSOR OF ga1 MUTANT, rga1 Recessive rga1 mutations were identified in a suppressor screen of an Arabidopsis GA biosynthetic mutation ga1-3 (67) . Mutations in the rga1 gene restore most of the vegetative phenotypes associated with the GA auxotrophy but do not suppress the germination defects (67) . In a wild-type background, the rga mutations cause adult plants to be slightly etiolated; however, for the most part these mutations lack distinctive phenotypes. The RGA1 gene shows high sequence similarity to GAI1, and this molecular redundancy may explain why single loss-of-function alleles of GAI1 and RGA1 are phenotypically subtle (66) . Construction of rga1 gai1 double mutants should resolve this issue. However, that loss-of-function alleles of GAI1 were never identified in the ga1-3 suppressor screen argues that these genes may only overlap in a subset of functions (67) .
Nevertheless, the functional and molecular redundancy of RGA1 and GAI1 demonstrates the difficulty of clearly identifying single switch genes in higher plants. Based on other genetic systems, it appears that a considerable number of loss-of-function mutations produce no obvious phenotype (9) . Although many of these genes may simply have nonessential functions under laboratory conditions, it is equally likely that some of these loci are functionally redundant. Although dominant gain-of-function mutants have the advantage of identifying functionally redundant signaling genes, the loss-of-function alleles in these same genes may not give the predicted opposite phenotype because another gene may genetically cover this function. A genetic solution to this problem is to identify mutations that enhance the phenotypes conferred by the first mutation but when isolated, by themselves are phenotypically innocuous. As with phenotypically neutral suppressor mutations, analysis of these types of synthetic enhancers are constrained by the sophistication of the genetics of the system. spindly1 MUTANT, spy1 The first spy1 mutations were identified by the ability of Arabidopsis seed to germinate in the presence of inhibitory concentrations of a GA biosynthetic inhibitor (33) . Although this type of screen formally does not qualify as a hunt for a genetic suppressor, subsequent screening for ga1-3 auxotrophic suppressors did identify more spy1 alleles (67) , which demonstrated that these screens are functionally similar. Recessive mutations at the spy1 locus result in partial suppression of all the defects associated with GA auxotrophy including defective germination and, therefore, this mutation confers a GA-independent phenotype to the plant (33) . Moreover, unlike loss-of-function rga1 and gai1 mutations, spy1 mutations in a wild-type genetic background have a reduced GA requirement for germination, increased internode length, and floral timing defects. The recessive nature of spy1 alleles suggests this gene encodes a negative regulator of GA response. The SPY1 gene shows sequence similarity to Ser (Thr)-O-linked acetylglucosamine (O-GlcNAc) transferases (32) . These enzymes glycosylate proteins and, in some cases, this modification can interfere with phosphorylation of a protein. Interestingly, RGA1 and GAI1 proteins both contain potential O-GlcNAc sites, hence, SPY1 may modify these two regulators.
One advantage of working on GA signal transduction pathways has been the elegant use of the barley aleurone cell system as a molecular assay for GA responses (26) . In this system, α-amylase mRNA is readily induced by addition of GA whereas ABA interferes with this induction. Microbombardment of aleurone cells with the barley homolog of SPY1 (HvSPY) prevents GA activation of α-amylase, supporting the role of SPY1 as a negative regulator (60) . Surprisingly, these transfection experiments also demonstrate a positive role for HvSPY in ABA responses. Possibly, the multiple effects of HvSPY occur because the O-GlcNAc transferase modifies separate target proteins in both GA and ABA response pathways. Alternatively, HvSPY may only enhance ABA signaling activity and this response reduces GA induced α-amylase induction. The demonstration that spy1 mutant seeds are partially insensitive to ABA as assayed by germination supports this idea (68) . However, it is also possible that increased GA signaling in the seed causes decreased ABA sensitivity. GA and ABA synthesis are temporally separated in Arabidopsis seeds, which indicates that the functions of these hormones on the establishment and breaking of dormancy is probably by different mechanisms (35, 39) . Active GA signaling in spy1 mutant embryos may be incompatible with ABA-induced seed functions and result in a less dormant seed. These issues cannot be resolved until the targets of the O-GlcNAc transferase are identified.
The duality of GA/ABA signaling responses in plants is often reflected in genetic screens. The first ABA-deficient mutants of Arabidopsis were originally identified by screening for suppressor mutations of the germination defect of a ga1 auxotroph (39) . By contrast, genetic screens for suppressors of the dominant ABA-insensitive mutation ABI1-1 enriches for mutations that are defective in GA synthesis or response (68) . The GA nonresponsive mutants are phenotypically indistinguishable from severe Arabidopsis GA auxotrophs and define one complementation group designated sly1. The alleles of sly1 are the first recessive GA-insensitive mutations and they probably identify a key regulator in GA reception; however, the ability to find such mutants as suppressors of mutants defective in ABA action was unexpected. ABA acts first to establish seed dormancy in the embryo and later GA works to reverse ABA-induced dormancy (39) . Mutants defective in GA signal transduction cannot germinate unless they have also acquired a mutation in a gene required for ABA synthesis or response. Physiological studies using an allelic series of ABA auxotrophic mutations have, however, demonstrated that the degree of ABA-induced seed dormancy is a reflection of the flux of the ABA signal (35) . Thus, the amount of GA needed to germinate seed will depend on the level of dormancy established by ABA, which will, in turn, be determined by the severity of the mutation affecting ABA signal flux. By genetically decreasing the ABA sensitivity of the seed, it is possible to identify mutations that have decreased GA sensitivity and that would normally not germinate by themselves. The observation that sly1 alleles do not germinate in an ABI1 wild-type background supports this model. The germination block imposed by normal ABA action in the seed may explain the dearth of recessive loss-of-function mutations in GA signaling genes. If true, suppressor screens against known ABA-response mutants under different selective conditions may identify new genes involved in GA signal transduction.
NEW TECHNOLOGIES
Although the use of classical genetic screens is a powerful tool in determining how genes specify the transduction of a hormone signal, this method is limited in the scope of genes it can identify. Traditional mutagenesis uses chemicals and ionizing radiation to create random mutations, which frequently cause a reduction or loss-of-gene function. These mutations are often difficult to recognize because they confer no obvious phenotype owing to genetic redundancy. In other model systems, an estimated two thirds of the genes have no phenotype under laboratory conditions (49) . No technology will replace traditional genetic screens, although new molecular techniques are now making it possible to more directly and efficiently pinpoint genes in specific signaling pathways. The success of these new screens requires efficient transformation and heterologous expression systems, both of which are available in Arabidopsis.
Activation-Transferred DNA Tagging Mutants.
The ability to express a gene in a cell where it is not normally active has various potential outcomes to a signaling pathway. Ectopic expression may have no effect on the transduction of the signal, which would indicate that the concentrations of molecular components of the signaling pathway are not essential in determining the current. Usually for a signaling cascade, however, this is not the case. In Saccharomyces cerevisiae, for example, the components of the pheromone signaling pathway are maintained at specific levels (58, 75) . Changing the stoichiometry of components in the pathway often causes the transduction current to increase or decrease depending on whether the specific component is positive or negative for the pathway. This observation has been the basis of screens in which increased expression of one gene can genetically suppress the phenotype of a mutation in another gene involved in the same process (58) .
In Arabidopsis, large-scale transformations with a t-DNA plasmid containing multiple enhancers allowed Kakimoto (34) to identify genes that confer cytokinin-independent growth to calli. One of these overexpressed genes, designated CKI1, shares sequence similarity to the two-component regulator family of proteins of which ETR1 is a member. CKI1 may be a downstream gene in the cytokinin signaling pathway that requires cytokinin for expression, and therefore overexpression of the gene uncouples it from cytokinin induction. The identification of two new two-component regulator genes in Arabidopsis by virtue of their rapid induction in response to cytokinin application supports such a contention (8) . It is also possible that CKI1 is a protein that requires cytokinin for activation and that increased expression of CKI1 overrides this hormonal need. On this theme, Kakimoto (34) has hypothesized that CKI1 could be a cytokinin receptor molecule that, when overexpressed, increases the ability of the cells to respond to the normally low endogenous levels of cytokinin found in calli. Although CKI1 may be a cytokinin receptor, binding of cytokinin to this protein has not been shown, and that no loss-of-function alleles exist makes it difficult to distinguish between these or other unanticipated possibilities.
Although these genetic screens hold much promise, most misexpression systems are at present constructed to overexpress proteins ubiquitously. Aside from the inability to control where and how much target protein is made, if ectopic expression of the gene is toxic in some tissues, it may be impossible to establish genetically tractable lines. Many of these problems, however, can be circumvented by the development of a modular GAL4 inducible system similar to one recently reported in Drosophila (63) .
Screens Involving Reporter Constructs
The molecular identification of genes induced by the application of a particular hormone was originally designed to identify genes that respond to the hormone after the signal has been transduced. However, these same downstream targets of the hormone signaling pathway can also be exploited to identify mutations that affect transduction of the hormone signal. The system first requires the fusion of an easily assayed reporter gene to the cis-acting control elements of a hormone-regulated promoter. Transgenic lines containing this construct are mutagenized and screened for second site mutations that alter expression of the reporter gene. Using this approach, the reporter gene luciferase was fused to the stress-induced responsive promoter RD29, and Arabidopsis seedlings with altered responses to low temperature, drought, salinity, and ABA were identified (31) . The specificity of the reporter-gene screens have two advantages over traditional genetic screens. First, the specificity of the phenotype being sought (i.e. increased or decreased expression) allows easy identification of mutants with no a priori bias on what the plants should look like. Second, the effects of the second site mutations on expression of the reporter gene may be more easily quantified than by using a physiological assay such as hypocotyl curvature. This latter quality may be extremely important in cases where a number of signaling pathways contribute to overall response such that mutations in any one of these only give subtle whole-plant phenotypes.
CONCLUSION
The studies reviewed here describe some of the characteristics of plant hormone signal transduction pathways and how these can be exploited to identify mutations in individual components in a hormone signaling pathway. Our understanding of hormone signaling will continue to expand quickly as more genetic variation is generated. As more hormone pathways are resolved at the molecular level and the logic of the system becomes apparent, it will become possible to answer questions on the role of these substances in plant evolution. For example, the never-ripe (Nr) mutation of tomato identifies an ETR1-like gene that contains an identical mutation to the Arabidopsis etr1-4 allele (77). However, unlike the Arabidopsis ETR1, the Nr gene lacks the response regulator domain and is induced by ethylene during fruit ripening. Thus, natural variation has produced an etr1-4 allelic change in a gene fundamentally different in structure and regulation. Introduction of the Nr gene in its wild-type and mutant forms into various Arabidopsis ethylene signaling mutants may uncover interactions that would not normally be observed by traditional mutagenesis and may lead to new methods of regulating these pathways. The conservation of a number of different hormone signaling components between Arabidopsis and other plant species argues that such experiments will be possible for all the hormone response pathways (23, 60, 76) . These and other experiments should provide new insights into how plant hormone signaling pathways have evolved and perhaps how these different strategies can be used to generate new functions for hormone signaling pathways.
